The Dow Jones Industrial Average and S&P traded at record levels in November, crossing the 16,000 and 1,800 point levels, respectively, for the first time. US equity markets continued to be fueled by loose Federal Reserve monetary policies, but were also heightened by modest economic advances, including improving manufacturing and consumer spending data, as well […]
Despite continuing weakness in many government and industrial markets, major US publicly held analytical instrument and lab product firms generated revenue growth in the calendar year third quarter, as demand from China and applied markets remained strong. In addition, select life science markets, such as those related to sequencing, were healthy. Businesses reported little overall […]
R&D spending by two thousand of the world’s largest companies grew 6.2% in fiscal 2012 to more than €538.8 billion ($690.8 billion = €0.78 = $1), with 70% of the companies increasing R&D expenditures, according to the recently published The 2012 EU Industrial R&D Investment Scoreboard. This compares to 6.2% growth for these companies in […]
Along with its 2013 Scoreboard, the EU also published a survey of industrial R&D trends. The survey is based on responses from 172 EU Scoreboard companies, which collectively spend €62 billion ($79 billion = €0.78 = $1) on R&D. The respondents expect their R&D expenditures to increase an average of 2.6% from 2013 to 2015. […]
Details of an acquisition not released when it is announced are occasionally available from a company’s SEC filings. The table below shows purchase prices disclosed in SEC filings. Additional details are also available. VWR disclosed that United Biochemicals, which it acquired in July (see IBO 7/15/13), has annual sales of around $12 million.
It is no surprise that the US budget sequestration, which took effect in March and resulted in cuts to the funding of major federal government research agencies (see IBO 3/15/13), is affecting instrument and lab product company revenues. Based on comments made on recent quarterly conference calls of publicly held instrument and laboratory product companies, […]
Fourteen of the 17 companies in the IBO Laboratory Sales Index reported quarterly earnings before this issue’s publication. Including estimates for Analytik Jena (Analytical Instrumentation and Life Science) Spectris (Materials Analysis) and Tecan, third quarter revenue for the IBO Laboratory Sales Index grew 1.4%, 0.9% excluding currency, to $6,143 million. Operating profit improved 1.7% to […]
A record breaking transaction overshadowed tepid merger and acquisition (M&A) activity in the instrument and laboratory product–related industry in 2013. Upon completion, Thermo Fisher Scientific’s acquisition of Life Technologies for $13.6 billion and assumed debt of $2.2 billion (see IBO 4/15/13) will represent the single largest transaction ever in the analytical instrument and laboratory product–related […]
The dependence on Federal stimulus spending along with positive earnings and stronger-than-expected manufacturing data in China elevated US equity markets to new highs in October. The Federal Reserve maintained its bond buying policy citing sluggish employment growth. The probability of any policy change for the remainder of the year is extremely low due to weak […]
In this issue, IBO presents its second of two articles this year detailing developments in patent infringement litigation involving instrument and lab product firms (see IBO 4/30/13). The pace of new litigation appears to have slowed. In addition, new settlements and rulings have put to rest, for now, some long running disputes. New Suits In […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
